Research Grade Anti-Human CLDN6 & CD137 Bispecific Antibody (NBL-028) (HX940046)

Precio(USD): $

Especificación:

Número:

Contáctenos

Vista general

Número de catálogo	HX940046
Descripción	Anti-Human CLDN6 & CD137 Bispecific Antibody (NBL-028) (HX940046) is a research-grade recombinant antibody targeting CD137. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especies	Human
Aplicaciones	ELISA, Functional assay, Research in vivo
Isotipo	Bispecific Antibody
ID de clon	NBL-028
Sistema de expresión	Mammalian Cells
Clonalidad	Monoclonal
Objetivo	Claudin-6, CLDN6, Skullin, Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA
Nivel de endotoxinas	Please contact the lab for this information.
Pureza	>95% purity as determined by SDS-PAGE.
Purificación	Protein A/G purified from cell culture supernatant.
Número de acceso	P56747 & Q07011
Forma	Liquid
Buffer de almacenamiento	0.01M PBS, pH 7.4. Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Nombres alternativos	Bispecific
Nota	For research use only. Not suitable for clinical or therapeutic use.

Imágenes

Referencias

Datasheet

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Vista general